MNOV Q3 2023 Earnings — MediciNova, Inc. Revenue & Financial Results | Market Cap Arena

MNOVMediciNova, Inc.

$69M

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M

Gross Profit

$1M100.0% margin

Operating Income

-$1M-114.7% margin

Net Income

-$723,107-72.3% margin

EPS (Diluted)

$-0.01

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$1M

Stock-Based Comp.

$219,142

Balance Sheet

Total Assets

$68M

Total Liabilities

$3M

Stockholders' Equity

$65M

Cash & Equivalents

$52M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$0	—
Gross Profit	$1M	$0	—
Operating Income	-$1M	-$4M	+70.6%
Net Income	-$723,107	-$4M	+80.2%